GeneDx Ownership | Who Owns GeneDx?


OverviewForecastRevenueFinancialsChartTranscripts

GeneDx Ownership Summary


GeneDx is owned by 107.49% institutional investors, 12.25% insiders. Corvex management lp is the largest institutional shareholder, holding 16.31% of WGS shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 3.06% of its assets in GeneDx shares.

WGS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGeneDx107.49%12.25%-19.74%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryDiagnostics & Research Stocks86.12%9.74%4.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Corvex management lp4.78M16.31%$328.46M
Casdin capital3.71M12.64%$254.50M
Blackrock funding, inc. /de1.71M5.82%$117.13M
Goldman sachs group1.67M5.69%$114.61M
Ark investment management1.61M5.49%$110.54M
William blair investment management1.40M4.77%$96.15M
Vanguard group1.19M4.13%$154.65M
Morgan stanley988.30K3.37%$67.85M
Oracle investment management922.45K3.23%$85.15M
Vanguard capital management879.00K3.00%$60.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oracle investment management922.45K58.40%$85.15M
Casdin capital3.71M12.74%$254.50M
Alamea verwaltungs gmbh185.99K10.20%$12.77M
Corvex management lp4.78M10.03%$328.46M
Gagnon advisors177.87K8.08%$12.21M
Gagnon securities524.87K7.11%$36.03M
Zweig-dimenna associates571.95K3.56%$39.26M
First light asset management783.92K3.27%$53.82M
Legal advantage investments67.05K1.61%$4.60M
Ashford capital management174.51K1.39%$11.21M

Top Buyers

HolderShares% AssetsChange
Corvex management lp4.78M10.03%1.56M
Casdin capital3.71M12.74%700.00K
Deep track capital, lp700.00K0.70%700.00K
William blair investment management1.40M0.29%625.38K
First light asset management783.92K3.27%541.00K

Top Sellers

HolderShares% AssetsChange
Westfield capital management co lp---1.37M
Invesco20.00K0.00%-520.23K
Raymond james financial123.42K0.00%-486.65K
Summit partners public asset management---479.42K
Prosight management, lp85.50K1.01%-437.96K

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp700.00K0.70%700.00K$48.05M
Norges bank273.10K0.00%273.10K$18.75M
Sixth street partners management company177.94K0.00%177.94K$12.22M
Silverarc capital management122.27K0.87%122.27K$8.39M
Hrt financial lp92.42K0.01%92.42K$6.34M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Assetmark-1.00
Gps wealth strategies group-1.00
Massmutual trust co fsb/adv-1.00
Pinnacle wealth planning services-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026237-6.32%31,533,6990.90%1070.95%142-60-20.00%
Mar 31, 2026155-49.68%15,076,123-51.36%560.48%83-45.03%49-53.33%
Dec 31, 2025233-19.93%20,170,201-32.99%700.63%118-24.36%78-8.24%
Sep 30, 202528216.53%29,207,814-0.14%1020.98%1513.42%8450.00%
Jun 30, 20252481.64%31,311,68210.33%1091.08%146-0.68%60-1.64%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite907.97K3.06%85.55K
ARK Innovation ETF876.61K2.94%-8.40K
Vanguard Morn Total Stk Mkt Idx Investor607.77K2.05%8.30K
Vanguard Total Stock Mkt Idx Inv607.77K2.05%8.30K
Vanguard MStar Total Stk Mkt Idx Invest607.77K2.04%-
iShares Russell 2000 ETF511.94K1.72%-9.12K
American Funds SMALLCAP World A459.49K1.55%66.34K
ARK Genomic Revolution449.18K1.51%98.97K
ARK Genomic Revolution ETF446.96K1.50%-9.40K
Amova ARK Disruptive Innovation A USD405.29K1.37%-22.90K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 01, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$31.19K
Jun 16, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$128.11K
Jun 16, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$45.41K
Jun 16, 2026Feeley Kevin CHIEF FINANCIAL OFFICERSell$53.08K
Jun 16, 2026Stueland Katherine CHIEF EXECUTIVE OFFICERSell$127.87K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q22711
2026 Q11038
2025 Q4-43
2025 Q3-39

WGS Ownership FAQ


Who Owns GeneDx?

GeneDx shareholders are primarily institutional investors at 107.49%, followed by 12.25% insiders and -19.74% retail investors. The average institutional ownership in GeneDx's industry, Diagnostics & Research Stocks, is 86.12%, which GeneDx exceeds.

Who owns the most shares of GeneDx?

GeneDx’s largest shareholders are Corvex management lp (4.78M shares, 16.31%), Casdin capital (3.71M shares, 12.64%), and Blackrock funding, inc. /de (1.71M shares, 5.82%). Together, they hold 34.76% of GeneDx’s total shares outstanding.

Does Blackrock own GeneDx?

BlackRock is not among the top 10 institutional shareholders of GeneDx.

Who is GeneDx’s biggest shareholder by percentage of total assets invested?

Oracle investment management is GeneDx’s biggest shareholder by percentage of total assets invested, with 58.40% of its assets in 922.45K GeneDx shares, valued at 85.15M$.

Who is the top mutual fund holder of GeneDx shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of GeneDx shares, with 3.06% of its total shares outstanding invested in 907.97K GeneDx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools